Karsten Beiderwellen1,
Thorsten D. Poeppel2, Verena Hartung-Knemeyer2,
Christian Buchbender3, Hilmar Kuehl1, Andreas Bockisch2,
Thomas C. Lauenstein1
1Department
of Diagnostic and Interventional Radiology and Neuroradiology, University
Hospital Essen, Essen, Germany; 2Clinic for Nuclear Medicine,
University Hospital Essen, Essen, Germany; 3Department of
Diagnostic and Interventional Radiology, University Hospital Dusseldorf,
Dusseldorf, Germany
The current goldstandard in diagnostic imaging consists of PET/CT with somatostatin-analogues such as 68Ga-DOTATOC. Due to the superb soft tissue contrast of MRI and the tendency towards early liver metastases, promising results on retrospective PET-MRI-fusion have been suggested for NETs. Since this method is time consuming and often defective, it is rarely performed in clinical routine. This is the first study on integrated PET/MRI with 68Ga-DOTATOC demonstrating its potential in whole-body staging of NETs, especially in the detection of NET liver metastases.